TOP TIERMARKET NEWSWIRE
News & sentiment

EUPRAXIA PHARMACEUTI Equity (EPRX) — News & AI sentiment

EUPRAXIA PHARMACEUTI Equity (EPRX) news roundup. 2 stories in the last 24 hours, 2 in the past week, 3 over 30 days. Average 24-hour sentiment is 42/100 — neutral (50 is neutral). No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
2
avg sentiment 42/100
7d stories
2
avg sentiment 42/100
30d stories
3
avg sentiment 49/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

EPRX news in the last 24 hours, 7 days, 30 days and 90 days

How much EPRX coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowEPRX storiesAvg AI sentimentRead
Last 24 hours242/100EPRX headlines →
Last 7 days242/100EPRX headlines →
Last 30 days349/100EPRX headlines →
Last 90 days652.5/100EPRX headlines →

Latest stories on EPRX

Eupraxia Pharmaceuticals reports Q2 results
Seeking Alpha34 · bearishearnings
5h ago
5h ago
Jul 13
Jul 7
Jun 19
May 28
Open EPRX in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →